Hong Kong, China

Xiaoxuan Liu

This inventor holds 1 USPTO granted patent. Top assignee: City University of Hong Kong. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaoxuan Liu. Retrieved from https://idiyas.com/inventor/xiaoxuan-liu-aydk30oj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Xiaoxuan Liu in Treating Hypervirulent Infections

Introduction

Xiaoxuan Liu is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of medicine, particularly in the treatment of hypervirulent infections. His innovative approach combines the use of antibiotics with other therapeutic agents to enhance treatment efficacy.

Latest Patents

Xiaoxuan Liu holds 1 patent for his work titled "Methods for treating hypervirulent infection." This patent outlines methods for treating a hypervirulent (hvKp) infection in a subject in need thereof. The method involves co-administering a therapeutically effective amount of an antibiotic and a non-steroidal anti-inflammatory drug or a signal transducer and activator of transcription 1 inhibitor to the subject.

Career Highlights

Xiaoxuan Liu is affiliated with the City University of Hong Kong, where he conducts research and develops innovative solutions in the medical field. His work has garnered attention for its potential impact on treating serious infections.

Collaborations

Xiaoxuan Liu collaborates with esteemed colleagues such as Sheng Chen and Guan Yang. Their combined expertise contributes to advancing research and innovation in their respective fields.

Conclusion

Xiaoxuan Liu's contributions to the treatment of hypervirulent infections highlight the importance of innovation in medicine. His work exemplifies how targeted therapies can improve patient outcomes and advance healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…